Author

D A Sychev

Observed names: D. A. Sychev, D.A. Sychev

OpenAlex ID: A5113720690

[Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: the first meta-analysis of Russian prospective studies].

2014 · D A Sychev, D V Ivashchenko, et al. · PubMed · 4

[CYP2C9 and VKORC1 gene polymorphism and acenocoumarol anticoagulant activity in Russian patients at high risk of thromboembolic complications].

2011 · D A Sychev, I V Ignat'ev, et al. · PubMed · 4

[The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation].

2007 · D A Sychev, Iu A Mikheeva, et al. · PubMed · 3

[Cranberry preparations in urological practice: view of a clinical pharmacologist].

2011 · D A Sychev · PubMed · 2

Clinico-pharmacological aspects of using new oral anticoagulants in patients with atrial fibrillation

2015 · D.A. Sychev, A.V. Kryukov, et al. · Russian Heart Journal · 1

[Bleeding in the appointment of dabigatran in the patients with renal insufficiency caused by coadministration of spironolactone and ACE inhibitors].

2013 · D A Andreev, Z K Gappoeva, et al. · PubMed · 1

[Valproic acid pharmacogenetics in an individual approach to treatment of women of childbearing age with epilepsy].

2011 · N A Snaĭder, D A Sychev, et al. · PubMed · 1

[Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study].

2010 · D A Sychev, I M Antonov, et al. · PubMed · 1

[Relationship between warfarin dosing and activity of CYP2C9 assessed by the content of losartan and its metabolite E-3174 in the urine of patients with mechanical prosthetic heart valves].

2013 · S M Arslanbekova, D A Sychev, et al. · PubMed

[Which of algorithms of warfarin dosing based on results of pharmacogenetic testing is suitable for patients in Russia].

2010 · D A Sychev, I M Antonov, et al. · PubMed

[A case of gastrointestinal hemorrage due to warfarin interaction with nalidixic acid resulting in massive blood loss].

2009 · D A Sychev, O A Nizovtseva, et al. · PubMed

[Problem of antibiotic interaction with nonsteroid antiinflammatory agents (minireview)].

2008 · V A Dmitriev, D A Sychev, et al. · PubMed

[Clinical pharmacogenetics of antifungals].

2008 · N S Semenov, D A Sychev · PubMed

[Importance of genetic polymorphism of cytochrome P450 isoenzymes for the choice and regimes of antidepressant and antipsychotic dosing on an individual basis].

2008 · M I Savel'eva, D A Sychev, et al. · PubMed

[The role of changes in the functional activity and the amount of p-glycoprotein in drug pharmacokinetics].

2007 · G V Ramenskaia, S L Faĭnshteĭn, et al. · PubMed

[Clinical significance of the pharmacokinetic interactions between drugs and phytopreparations].

2006 · D A Sychev, V G Kukes, et al. · PubMed

[The clinical pharmacology of beta-adrenoblockers].

2006 · D A Sychev, G V Ramenskaia, et al. · PubMed

ÇëÖ ãà èêéãéçÉàêéÇÄççõÖ ãÖäÄêëíÇÖççõÖ îéêåõ çàîÖÑàèàçÄ éÑàçÄäéÇõ

2006 · V. G. Kukes, D. A. Sychev · CyberLeninK (CyberLeninka)

[Functional changes of myocardial adrenoreceptors in patients with chronic cardiac insufficiency].

2005 · A K Starodubtsev, D E Arkhipova, et al. · PubMed

Pharmacogenetics in rheumatology: drug therapy individualization perspectives

2005 · D. A. Sychev, F V Ignatiev, et al. · Rheumatology Science and Practice

Genetic determinants of indirect anticoagulants’ sensitivity: VKORC1 and APOE gene polymorphism

2005 · D. A. Sychev, I. V. Ignatyev, et al. · Russian Cardiology Journal (Russian Cardiology Society)

PDF

[Safety of food supplements containing plant components].

2005 · V G Kukes, V M Bulaev, et al. · PubMed

[Activity of myocardial sympathetic-adrenal system with various volume of viable myocardium in patients with chronic cardiac failure].

2004 · V G Kukes, D A Sychev, et al. · PubMed

Works count: 23

Citation count: 17

H-index: 3

I10-index: